Uroplasty, Inc. (AMEX: UPI), a global medical device company, is focused on developing, manufacturing, and marketing products for the minimally invasive treatment of voiding dysfunctions and pelvic disorders. The company offers a wide range of products that meet the demands of healthcare professionals and patients. Their devices help healthcare professionals increase the efficiency of their treatment options while reducing patient risk. For further information, visit the Company’s web site at www.uroplasty.com.
- 17 years ago
QualityStocks
Uroplasty, Inc. (AMEX: UPI)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Plum Acquisition Corp. IV. (NASDAQ: PLMK) Signs LOI With American Critical Resources to Advance U.S. Energy and Critical Minerals Supply
Plum Acquisition (NASDAQ: PLMK) announced it has entered into a non-binding letter of intent with American Critical Resources, a…
-
Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Completes 2025 Field Program at Atikokan REE Property
Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid…
-
Soligenix Inc. (NASDAQ: SNGX) Advances Ricin Vaccine amid Toxin Threat
A recent report from India is a stark reminder of ricin’s accessibility and the pressing…